Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

DOPAMINERGIC DRUGS vs other drugs

Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether DOPAMINERGIC DRUGS changes tardive dyskinesia: No clinically important improvement compared with OTHER DRUGS (very low certainty).

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.93 [0.45, 1.95]
1 study · 13 participants
Very low

DOPAMINERGIC DRUGS vs placebo

Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia

DOPAMINERGIC DRUGS may leads to lower tardive dyskinesia: No clinically important improvement compared with PLACEBO (low certainty).

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.52 [0.29, 0.96]
1 study · 20 participants
Low

NORADRENERGIC DRUGS vs DOPAMINERGIC DRUGS

Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether NORADRENERGIC DRUGS changes tardive dyskinesia: No clinically important improvement compared with DOPAMINERGIC DRUGS (very low certainty).

1 finding from 1 review

Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.6 [0.19, 1.86]
1 study · 20 participants
Very low